Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Down 81.5% in July

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) saw a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 3,905 shares, a drop of 81.5% from the June 30th total of 21,160 shares. Based on an average daily volume of 46 shares, the short-interest ratio is currently 84.9 days.

Analyst Ratings Changes

Separately, Morgan Stanley raised shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Towa Pharmaceutical Price Performance

Shares of OTCMKTS TWAPF opened at $26.00 on Friday. Towa Pharmaceutical has a 1 year low of $25.71 and a 1 year high of $26.00. The stock’s 50-day simple moving average is $25.53 and its 200-day simple moving average is $25.40.

Towa Pharmaceutical Company Profile

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.